Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study)
Titel:
Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study)
Auteur:
Musto, Pellegrino Simeon, Vittorio Cascavilla, Nicola Falcone, Antonietta Petrucci, Maria Teresa Cesini, Laura Raimondo, Francesco Di Conticello, Concetta Ria, Roberto Catalano, Lucio Salvatore, Dalila Mastrullo, Lucia Gagliardi, Alfredo Villani, Oreste Pietrantuono, Giuseppe D’Arena, Giovanni Mansueto, Giovanna Bringhen, Sara Genuardi, Mariella Renzo, Nicola Di Reddiconto, Giovanni Fragasso, Alberto Caravita, Tommaso Scapicchio, Daniele Marziano, Gioacchino Boccadoro, Mario Mangiacavalli, Silvia Corso, Alessandro